Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The closing price of Semler Scientific Inc (NASDAQ: SMLR) was $35.37 for the day, up 2.64% from the previous closing price of $34.46. In other words, the price has increased by $2.64 from its previous closing price. On the day, 0.57 million shares were traded. SMLR stock price reached its highest trading level at $35.5988 during the session, while it also had its lowest trading level at $34.14.
Ratios:
Our analysis of SMLR’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 81.04 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 49.11. For the most recent quarter (mrq), Quick Ratio is recorded 0.51 and its Current Ratio is at 0.52. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On July 08, 2025, The Benchmark Company started tracking the stock assigning a Buy rating and target price of $101.
B. Riley Securities Downgraded its Buy to Neutral on November 02, 2022, whereas the target price for the stock was revised from $60 to $45.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 10 ’24 when Murphy-Chutorian Douglas sold 75,000 shares for $60.12 per share. The transaction valued at 4,508,683 led to the insider holds 65,083 shares of the business.
Murphy-Chutorian Douglas sold 25,000 shares of SMLR for $1,556,123 on Dec 11 ’24. The CEO now owns 55,000 shares after completing the transaction at $62.24 per share. On Dec 10 ’24, another insider, Douglas Murphy-Chutorian, who serves as the CEO of the company, bought 100,000 shares for $62.00 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SMLR now has a Market Capitalization of 500064576 and an Enterprise Value of 480586112. For the stock, the TTM Price-to-Sale (P/S) ratio is 16.66 while its Price-to-Book (P/B) ratio in mrq is 2.10. Its current Enterprise Value per Revenue stands at 9.763 whereas that against EBITDA is 37.4.
Stock Price History:
The Beta on a monthly basis for SMLR is 1.41, which has changed by 0.2852471 over the last 52 weeks, in comparison to a change of 0.20799685 over the same period for the S&P500. Over the past 52 weeks, SMLR has reached a high of $81.56, while it has fallen to a 52-week low of $21.77. The 50-Day Moving Average of the stock is -7.44%, while the 200-Day Moving Average is calculated to be -18.37%.
Shares Statistics:
SMLR traded an average of 1.08M shares per day over the past three months and 601720 shares per day over the past ten days. A total of 23.19M shares are outstanding, with a floating share count of 20.21M. Insiders hold about 12.86% of the company’s shares, while institutions hold 35.53% stake in the company. Shares short for SMLR as of 1752537600 were 2794648 with a Short Ratio of 2.59, compared to 1749772800 on 2603478. Therefore, it implies a Short% of Shares Outstanding of 2794648 and a Short% of Float of 23.25.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The market rating of Semler Scientific Inc (SMLR) is currently shaped by the ongoing analysis conducted by 2.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.08, with high estimates of $0.04 and low estimates of -$0.19.
Analysts are recommending an EPS of between -$2.87 and -$2.87 for the fiscal current year, implying an average EPS of -$2.87. EPS for the following year is -$0.23, with 2.0 analysts recommending between $0.09 and -$0.56.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 3 analysts. It ranges from a high estimate of $8.26M to a low estimate of $7.71M. As of the current estimate, Semler Scientific Inc’s year-ago sales were $13.51MFor the next quarter, 3 analysts are estimating revenue of $7.89M. There is a high estimate of $8.35M for the next quarter, whereas the lowest estimate is $7.31M.
Based on 3 analysts’ estimates, the company’s revenue will be $32.2M in the next fiscal year. The high estimate is $34.22M and the low estimate is $30.36M.
